SITAGLIPTINA 25 mg Film-Coated Tablets
How to use SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the User
Sitagliptina Olpha 25mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor, pharmacist, or nurse.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the Package Leaflet
- What is Sitagliptina Olpha and what is it used for
- What you need to know before you take Sitagliptina Olpha
- How to take Sitagliptina Olpha
- Possible side effects
- Storage of Sitagliptina Olpha
- Contents of the pack and other information
1. What is Sitagliptina Olpha and what is it used for
This medicine contains the active substance sitagliptin, which belongs to a class of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) that reduce blood sugar levels in adult patients with type 2 diabetes mellitus.
This medicine helps to increase the amounts of insulin produced after a meal and decreases the amount of sugar produced by the body.
Your doctor has prescribed this medicine to help you reduce your blood sugar level, which is too high due to your type 2 diabetes. This medicine can be used alone or in combination with other medicines (insulin, metformin, sulfonylureas, or glitazones) that reduce blood sugar levels, and that you may already be taking for your diabetes, together with a diet and exercise program.
What is type 2 diabetes?
Type 2 diabetes is a condition where your body does not produce enough insulin, and the insulin that it does produce does not work as well as it should. Your body may also produce too much sugar. When this happens, sugar (glucose) builds up in the blood. This can lead to serious medical problems, such as heart disease, kidney disease, blindness, and amputation.
2. What you need to know before you take Sitagliptina Olpha
Do not take Sitagliptina Olpha
- if you are allergic to sitagliptin or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before you start taking this medicine.
There have been reports of pancreatitis (inflammation of the pancreas) in patients treated with sitagliptin (see section 4).
If you notice blisters on your skin, it may be a sign of a disease called bullous pemphigoid. Your doctor may ask you to stop taking sitagliptina.
Tell your doctor if you have or have had:
- pancreatitis (inflammation of the pancreas)
- gallstones, alcohol dependence, or very high levels of triglycerides (a type of fat) in the blood. These medical conditions may increase your risk of developing pancreatitis (see section 4)
- type 1 diabetes
- diabetic ketoacidosis (a complication of diabetes that causes high blood sugar levels, rapid weight loss, nausea, or vomiting)
- any kidney problems you have now or have had in the past
- an allergic reaction to sitagliptina (see section 4)
It is unlikely that this medicine will cause low blood sugar because it does not work when your blood sugar levels are low. However, when this medicine is used in combination with a medicine that contains a sulfonylurea or with insulin, low blood sugar (hypoglycemia) may occur. Your doctor may reduce the dose of your sulfonylurea or insulin medicine.
Children and adolescents
Children and adolescents under 18 years should not use this medicine. It is not effective in children and adolescents aged between 10 and 17 years. It is not known if this medicine is safe and effective when used in children under 10 years.
Other medicines and Sitagliptina Olpha
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
In particular, tell your doctor if you are taking digoxin (a medicine used to treat irregular heartbeat and other heart problems). Your doctor may need to check the level of digoxin in your blood if you are taking sitagliptina.
Taking Sitagliptina Olpha with food and drinks
You can take this medicine with or without food and drinks.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take this medicine during pregnancy.
It is not known if this medicine passes into breast milk. Do not take this medicine if you are breast-feeding or planning to breast-feed.
Driving and using machines
This medicine has no or negligible influence on the ability to drive and use machines. However, dizziness and somnolence have been reported, which may affect your ability to drive or use machines.
Taking this medicine with the medicines called sulfonylureas or with insulin may cause low blood sugar, which may affect your ability to drive or use machines or work without a safe support.
Sitagliptina Olpha contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially “sodium-free”.
3. How to take Sitagliptina Olpha
Follow exactly the instructions of your doctor for taking this medicine. If you are not sure, ask your doctor or pharmacist again.
The recommended dose is:
- one 100 mg film-coated tablet
- once a day
- by mouth
If you have kidney problems, your doctor may prescribe lower doses (such as 25 mg or 50 mg).
You can take this medicine with or without food and drinks.
Your doctor may prescribe this medicine alone or with other medicines that also reduce blood sugar levels.
Diet and exercise may help your body use sugar better. It is important that you follow the diet and exercise recommended by your doctor while taking sitagliptina.
If you take more Sitagliptina Olpha than you should
If you take more of this medicine than you should, contact your doctor immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Sitagliptina Olpha
If you forget a dose, take it as soon as you remember. If you do not remember until the time of your next dose, then skip the missed dose and continue with your regular schedule. Do not take a double dose of this medicine.
If you stop taking Sitagliptina Olpha
Keep taking this medicine as long as your doctor tells you to, so that you can continue to control your blood sugar levels. You should not stop taking this medicine without first talking to your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
STOP taking sitagliptina and contact a doctor immediatelyif you notice any of the following serious side effects:
- Severe and persistent abdominal pain (in the stomach area) that may radiate to the back, with or without nausea and vomiting, as these may be signs of pancreatitis.
If you have a severe allergic reaction (frequency not known), including skin rash, urticaria, blisters on the skin/peeling of the skin, and swelling of the face, lips, tongue, and throat that may cause difficulty breathing or swallowing, stop taking this medicine and consult your doctor immediately. Your doctor will prescribe a medicine to treat the allergic reaction and change your medicine for the treatment of diabetes.
Some patients experienced the following side effects after adding sitagliptina to their treatment with metformin:
Common (may affect up to 1 in 10 people): low blood sugar, nausea, flatulence, vomiting.
Uncommon (may affect up to 1 in 100 people): stomach pain, diarrhea, constipation, somnolence.
Some patients experienced different types of stomach discomfort when starting the combination of sitagliptina and metformin together (frequency classified as common).
Some patients experienced the following side effects while taking sitagliptina in combination with a sulfonylurea and metformin:
Very common (may affect more than 1 in 10 people): low blood sugar
Common: constipation
Some patients experienced the following side effects while taking sitagliptina and pioglitazone:
Common: flatulence, swelling of hands or feet
Some patients experienced the following side effects while taking sitagliptina in combination with pioglitazone and metformin:
Common: swelling of hands or feet
Some patients experienced the following side effects while taking sitagliptina in combination with insulin (with or without metformin):
Common: flu
Uncommon: dry mouth
Some patients experienced the following side effects while taking sitagliptina alone during clinical trials or after approval, alone and/or with other diabetes medicines:
Common: low blood sugar, headache, upper respiratory tract infection, nasal congestion or runny nose, and sore throat, arthrosis, pain in the arm or leg
Uncommon: dizziness, constipation, itching
Rare: reduced number of platelets
Frequency not known: kidney problems (which may require dialysis), vomiting, joint pain, muscle pain, back pain, interstitial lung disease, bullous pemphigoid (a type of blister on the skin)
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Sitagliptina Olpha
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and on the carton after EXP. The expiry date is the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
6. Contents of the pack and other information
Composition of Sitagliptina Olpha
- The active substance is sitagliptin:
- Each film-coated tablet contains sitagliptin hydrochloride monohydrate, equivalent to 25 mg of sitagliptin.
- The other ingredients (excipients) are:
Core of the tablet: calcium hydrogen phosphate, microcrystalline cellulose 102 (E460), sodium croscarmellose (E468), anhydrous colloidal silica, sodium stearyl fumarate, and magnesium stearate (E470b).
Coating material: poly(vinyl alcohol) (E1203), titanium dioxide (E171), macrogol 3350 (E1521), talc (E553b), yellow iron oxide (E172), red iron oxide (E172), and black iron oxide (E172).
Appearance of the product and contents of the pack
Film-coated tablets, round and pink.
Opaque blisters (PVC/PE/PVDC and aluminum). Packs of 28, 30, 56, 98 film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Olpha AS,
Rupnicu iela 5,
Olaine, Olaines novads, LV-2114,
Latvia
Manufacturer
SAG MANUFACTURING S.L.U
Carretera Nacional 1, km.36
San Agustín del Guadalix
28750 Madrid, Spain
or
Galenicum Healthcare S.L.U
Carrer de Sant Gabriel, 50
Esplugues de Llobregat
08950 Barcelona, Spain
Date of last revision of this leaflet:12/2024.
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
- Country of registration
- Dosage formTABLET, 25 mg
- ATC codeA10BH01
- Active substance
- Prescription requiredYes
- Manufacturer
- CompositionCROSCARMELOSA SODICA (5 mg mg), FUMARATO DE ESTEARILO Y SODIO (2,5 mg mg)
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETSDosage form: TABLET, 100 mgActive substance: sitagliptinManufacturer: Laboratorios Alter S.A.Prescription requiredDosage form: TABLET, 25 mgActive substance: sitagliptinManufacturer: Laboratorios Alter S.A.Prescription requiredDosage form: TABLET, 50 mgActive substance: sitagliptinManufacturer: Laboratorios Alter S.A.Prescription required
Online doctors for SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS
Discuss questions about SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Book a video appointment 
Book a video appointment Get SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS Prescription Online
Fill in a 2-min form
Tell us your symptoms, history, and what medicine you're requesting.
Pick a doctor or let us assign
Choose a specialist or we'll match you with the next available doctor.
Doctor reviews your case
Usually within 30 minutes. They may ask follow-up questions via chat.
Collect from any pharmacy
Electronic prescription sent to your email — valid across Spain.
Frequently Asked Questions
Is a prescription required for SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS?
SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS?
The active ingredient in SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS is sitagliptin. This information helps identify medicines with the same composition but different brand names.
Who manufactures SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS?
SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS is manufactured by Olpha As. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
How to buy SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS in Spain?
Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.
You can buy SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.
To obtain a prescription, you can use Oladoctor:
What are the alternatives to SITAGLIPTIN OLPHA 25 mg FILM-COATED TABLETS?
Other medicines with the same active substance (sitagliptin) include DISIT 100 mg FILM-COATED TABLETS, DISIT 25 mg FILM-COATED TABLETS, DISIT 50 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
